{"denoms":[{"counts":[{"groupId":"BG000","value":"259"},{"groupId":"BG001","value":"263"},{"groupId":"BG002","value":"522"}],"units":"Participants"}],"groups":[{"description":"Participants received daratumumab intravenous infusion (Dara IV) 16 milligrams per kilogram (mg/kg) once weekly in Cycle 1 and 2, every 2 weeks in Cycle 3 to 6, every 4 weeks thereafter until disease progression, unacceptable toxicity, withdrawal of consent, the investigator decides to stop treatment, or the start of subsequent anticancer therapy. The duration for each cycle was 28 days.","id":"BG000","title":"Daratumumab IV"},{"description":"Participants received daratumumab 1800 mg subcutaneous injection (Dara SC) co-formulated with recombinant human hyaluronidase (rHuPH20) 2000 Units per milliliter (U/mL), once weekly in Cycle 1 and 2, every 2 weeks in Cycle 3 to 6, every 4 weeks thereafter until disease progression, unacceptable toxicity, withdrawal of consent, the investigator decides to stop treatment, or the start of subsequent anticancer therapy. The duration for each cycle was 28 days.","id":"BG001","title":"Daratumumab SC"},{"description":"Total of all reporting groups","id":"BG002","title":"Total"}],"measures":[{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","spread":"10.16","value":"66.8"},{"groupId":"BG001","spread":"9.11","value":"65.3"},{"groupId":"BG002","spread":"9.66","value":"66.1"}]}]}],"dispersionType":"STANDARD_DEVIATION","paramType":"MEAN","title":"Age, Continuous","unitOfMeasure":"years"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"110"},{"groupId":"BG001","value":"127"},{"groupId":"BG002","value":"237"}],"title":"Female"},{"measurements":[{"groupId":"BG000","value":"149"},{"groupId":"BG001","value":"136"},{"groupId":"BG002","value":"285"}],"title":"Male"}]}],"paramType":"COUNT_OF_PARTICIPANTS","title":"Sex: Female, Male","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"9"},{"groupId":"BG001","value":"14"},{"groupId":"BG002","value":"23"}],"title":"Hispanic or Latino"},{"measurements":[{"groupId":"BG000","value":"227"},{"groupId":"BG001","value":"225"},{"groupId":"BG002","value":"452"}],"title":"Not Hispanic or Latino"},{"measurements":[{"groupId":"BG000","value":"23"},{"groupId":"BG001","value":"24"},{"groupId":"BG002","value":"47"}],"title":"Unknown or Not Reported"}]}],"paramType":"COUNT_OF_PARTICIPANTS","title":"Ethnicity (NIH/OMB)","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG001","value":"1"},{"groupId":"BG002","value":"1"}],"title":"American Indian or Alaska Native"},{"measurements":[{"groupId":"BG000","value":"40"},{"groupId":"BG001","value":"32"},{"groupId":"BG002","value":"72"}],"title":"Asian"},{"measurements":[{"groupId":"BG000","value":"1"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"1"}],"title":"Native Hawaiian or Other Pacific Islander"},{"measurements":[{"groupId":"BG000","value":"5"},{"groupId":"BG001","value":"9"},{"groupId":"BG002","value":"14"}],"title":"Black or African American"},{"measurements":[{"groupId":"BG000","value":"201"},{"groupId":"BG001","value":"207"},{"groupId":"BG002","value":"408"}],"title":"White"},{"measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"0"}],"title":"More than one race"},{"measurements":[{"groupId":"BG000","value":"12"},{"groupId":"BG001","value":"14"},{"groupId":"BG002","value":"26"}],"title":"Unknown or Not Reported"}]}],"paramType":"COUNT_OF_PARTICIPANTS","title":"Race (NIH/OMB)","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"15"},{"groupId":"BG001","value":"13"},{"groupId":"BG002","value":"28"}]}],"title":"AUSTRALIA"},{"categories":[{"measurements":[{"groupId":"BG000","value":"10"},{"groupId":"BG001","value":"15"},{"groupId":"BG002","value":"25"}]}],"title":"BRAZIL"},{"categories":[{"measurements":[{"groupId":"BG000","value":"16"},{"groupId":"BG001","value":"20"},{"groupId":"BG002","value":"36"}]}],"title":"CANADA"},{"categories":[{"measurements":[{"groupId":"BG000","value":"20"},{"groupId":"BG001","value":"16"},{"groupId":"BG002","value":"36"}]}],"title":"CZECH REPUBLIC"},{"categories":[{"measurements":[{"groupId":"BG000","value":"6"},{"groupId":"BG001","value":"10"},{"groupId":"BG002","value":"16"}]}],"title":"FRANCE"},{"categories":[{"measurements":[{"groupId":"BG000","value":"1"},{"groupId":"BG001","value":"6"},{"groupId":"BG002","value":"7"}]}],"title":"GREECE"},{"categories":[{"measurements":[{"groupId":"BG000","value":"5"},{"groupId":"BG001","value":"8"},{"groupId":"BG002","value":"13"}]}],"title":"ISRAEL"},{"categories":[{"measurements":[{"groupId":"BG000","value":"10"},{"groupId":"BG001","value":"16"},{"groupId":"BG002","value":"26"}]}],"title":"ITALY"},{"categories":[{"measurements":[{"groupId":"BG000","value":"24"},{"groupId":"BG001","value":"18"},{"groupId":"BG002","value":"42"}]}],"title":"JAPAN"},{"categories":[{"measurements":[{"groupId":"BG000","value":"39"},{"groupId":"BG001","value":"26"},{"groupId":"BG002","value":"65"}]}],"title":"POLAND"},{"categories":[{"measurements":[{"groupId":"BG000","value":"28"},{"groupId":"BG001","value":"27"},{"groupId":"BG002","value":"55"}]}],"title":"RUSSIAN FEDERATION"},{"categories":[{"measurements":[{"groupId":"BG000","value":"7"},{"groupId":"BG001","value":"4"},{"groupId":"BG002","value":"11"}]}],"title":"SOUTH KOREA"},{"categories":[{"measurements":[{"groupId":"BG000","value":"14"},{"groupId":"BG001","value":"12"},{"groupId":"BG002","value":"26"}]}],"title":"SPAIN"},{"categories":[{"measurements":[{"groupId":"BG000","value":"18"},{"groupId":"BG001","value":"18"},{"groupId":"BG002","value":"36"}]}],"title":"SWEDEN"},{"categories":[{"measurements":[{"groupId":"BG000","value":"6"},{"groupId":"BG001","value":"8"},{"groupId":"BG002","value":"14"}]}],"title":"TAIWAN"},{"categories":[{"measurements":[{"groupId":"BG000","value":"22"},{"groupId":"BG001","value":"25"},{"groupId":"BG002","value":"47"}]}],"title":"UKRAINE"},{"categories":[{"measurements":[{"groupId":"BG000","value":"16"},{"groupId":"BG001","value":"17"},{"groupId":"BG002","value":"33"}]}],"title":"UNITED KINGDOM"},{"categories":[{"measurements":[{"groupId":"BG000","value":"2"},{"groupId":"BG001","value":"4"},{"groupId":"BG002","value":"6"}]}],"title":"UNITED STATES"}],"paramType":"COUNT_OF_PARTICIPANTS","title":"Region of Enrollment","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"94"},{"groupId":"BG001","value":"82"},{"groupId":"BG002","value":"176"}]}],"title":"Stage I"},{"categories":[{"measurements":[{"groupId":"BG000","value":"89"},{"groupId":"BG001","value":"101"},{"groupId":"BG002","value":"190"}]}],"title":"Stage II"},{"categories":[{"measurements":[{"groupId":"BG000","value":"76"},{"groupId":"BG001","value":"79"},{"groupId":"BG002","value":"155"}]}],"title":"Stage III"},{"categories":[{"measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG001","value":"1"},{"groupId":"BG002","value":"1"}]}],"title":"Data missing or Unknown"}],"description":"Measure Description: The International Staging System (ISS) consists of following 3 stages - Stage I: serum beta2-microglobulin less than (\\<) 3.5 milligrams per liter (mg/L) and albumin greater than or equal to (\\>=) 3.5 grams (g) per 100 milliliter; Stage II: neither stage I nor stage III and Stage III: serum beta2-microglobulin \\>= 5.5 mg/L.","paramType":"COUNT_OF_PARTICIPANTS","title":"Stage of Disease (ISS)","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"175"},{"groupId":"BG001","value":"174"},{"groupId":"BG002","value":"349"}]}],"title":"Less than or equal to (<=) 4 Lines"},{"categories":[{"measurements":[{"groupId":"BG000","value":"84"},{"groupId":"BG001","value":"89"},{"groupId":"BG002","value":"173"}]}],"title":"Greater than (>) 4 Lines"}],"paramType":"COUNT_OF_PARTICIPANTS","title":"Number of prior lines","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"133"},{"groupId":"BG001","value":"125"},{"groupId":"BG002","value":"258"}]}],"title":"Both protease inhibitor (PI) and immunomodulatory drug (IMiD)"},{"categories":[{"measurements":[{"groupId":"BG000","value":"81"},{"groupId":"BG001","value":"67"},{"groupId":"BG002","value":"148"}]}],"title":"IMiD only"},{"categories":[{"measurements":[{"groupId":"BG000","value":"26"},{"groupId":"BG001","value":"41"},{"groupId":"BG002","value":"67"}]}],"title":"None"},{"categories":[{"measurements":[{"groupId":"BG000","value":"19"},{"groupId":"BG001","value":"30"},{"groupId":"BG002","value":"49"}]}],"title":"PI only"}],"paramType":"COUNT_OF_PARTICIPANTS","title":"Refractory status","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"92"},{"groupId":"BG001","value":"94"},{"groupId":"BG002","value":"186"}]}],"title":"<=65"},{"categories":[{"measurements":[{"groupId":"BG000","value":"105"},{"groupId":"BG001","value":"102"},{"groupId":"BG002","value":"207"}]}],"title":">65 - 85"},{"categories":[{"measurements":[{"groupId":"BG000","value":"61"},{"groupId":"BG001","value":"66"},{"groupId":"BG002","value":"127"}]}],"title":">85"},{"categories":[{"measurements":[{"groupId":"BG000","value":"1"},{"groupId":"BG001","value":"1"},{"groupId":"BG002","value":"2"}]}],"title":"Not Reported"}],"paramType":"COUNT_OF_PARTICIPANTS","title":"Weight group","unitOfMeasure":"Participants"}]}